Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Big thinking for adjuvants.

Literature DB >> 26544144

Big thinking for adjuvants.

Eric L Dane¹, Darrell J Irvine¹.

Abstract

Mesh：

Substances：

Year: 2015 PMID： 26544144 DOI： 10.1038/nbt.3398

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

9 in total

1. Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.

Authors: Melissa C Hanson; Monica P Crespo; Wuhbet Abraham; Kelly D Moynihan; Gregory L Szeto; Stephanie H Chen; Mariane B Melo; Stefanie Mueller; Darrell J Irvine
Journal: J Clin Invest Date: 2015-05-04 Impact factor: 14.808

Review 2. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.

Authors: Taro Kawai; Shizuo Akira
Journal: Immunity Date: 2011-05-27 Impact factor: 31.745

3. Rational design of small molecules as vaccine adjuvants.

Authors: Tom Y-H Wu; Manmohan Singh; Andrew T Miller; Ennio De Gregorio; Francesco Doro; Ugo D'Oro; David A G Skibinski; M Lamine Mbow; Simone Bufali; Ann E Herman; Alex Cortez; Yongkai Li; Bishnu P Nayak; Elaine Tritto; Christophe M Filippi; Gillis R Otten; Luis A Brito; Elisabetta Monaci; Chun Li; Susanna Aprea; Sara Valentini; Samuele Calabrό; Donatello Laera; Brunella Brunelli; Elena Caproni; Padma Malyala; Rekha G Panchal; Travis K Warren; Sina Bavari; Derek T O'Hagan; Michael P Cooke; Nicholas M Valiante
Journal: Sci Transl Med Date: 2014-11-19 Impact factor: 17.956

Review 4. The use of Toll-like receptor 7/8 agonists as vaccine adjuvants.

Authors: John P Vasilakos; Mark A Tomai
Journal: Expert Rev Vaccines Date: 2013-07 Impact factor: 5.217

Review 5. TLR-based immune adjuvants.

Authors: Folkert Steinhagen; Takeshi Kinjo; Christian Bode; Dennis M Klinman
Journal: Vaccine Date: 2010-08-14 Impact factor: 3.641

Review 6. Harnessing the power of the immune system to target cancer.

Authors: Gregory Lizée; Willem W Overwijk; Laszlo Radvanyi; Jianjun Gao; Padmanee Sharma; Patrick Hwu
Journal: Annu Rev Med Date: 2012-10-22 Impact factor: 13.739

7. Polyinosinic-polycytidylic acid is the most effective TLR adjuvant for SIV Gag protein-induced T cell responses in nonhuman primates.

Authors: Haesun Park; Lauren Adamson; Tae Ha; Karl Mullen; Shoko I Hagen; Arys Nogueron; Andrew W Sylwester; Michael K Axthelm; Al Legasse; Michael Piatak; Jeffrey D Lifson; Juliana M McElrath; Louis J Picker; Robert A Seder
Journal: J Immunol Date: 2013-03-15 Impact factor: 5.422

8. HPMA copolymers: origins, early developments, present, and future.

Authors: Jindrich Kopecek; Pavla Kopecková
Journal: Adv Drug Deliv Rev Date: 2009-11-14 Impact factor: 15.470

9. In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity.

Authors: Geoffrey M Lynn; Richard Laga; Patricia A Darrah; Andrew S Ishizuka; Alexandra J Balaci; Andrés E Dulcey; Michal Pechar; Robert Pola; Michael Y Gerner; Ayako Yamamoto; Connor R Buechler; Kylie M Quinn; Margery G Smelkinson; Ondrej Vanek; Ryan Cawood; Thomas Hills; Olga Vasalatiy; Kathrin Kastenmüller; Joseph R Francica; Lalisa Stutts; Janine K Tom; Keun Ah Ryu; Aaron P Esser-Kahn; Tomas Etrych; Kerry D Fisher; Leonard W Seymour; Robert A Seder
Journal: Nat Biotechnol Date: 2015-10-26 Impact factor: 54.908

9 in total

7 in total

1. Bio-inspired virus-like nanovesicle for effective vaccination.

Authors: Peng Mi; Pengfei Zhang; Gang Liu
Journal: Hum Vaccin Immunother Date: 2016-05-04 Impact factor: 3.452

Review 2. Smart Radiation Therapy Biomaterials.

Authors: Wilfred Ngwa; Francis Boateng; Rajiv Kumar; Darrell J Irvine; Silvia Formenti; Twalib Ngoma; Carsten Herskind; Marlon R Veldwijk; Georg Lars Hildenbrand; Michael Hausmann; Frederik Wenz; Juergen Hesser
Journal: Int J Radiat Oncol Biol Phys Date: 2016-11-01 Impact factor: 7.038